Skip to content
ANAVEX
ANAVEX
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US
Search
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US
View allAlzheimer's DiseaseAnavex2-73EventsNews ReleasesPDDPIPELINEPressRett Syndrome

Anavex Raises $2.6-Million in Private Placement and Conversion of Liabilities, Enters Into $10-Million Financing Commitment and Appoints CEO

July 8, 2013

Anavex Invited to File Funding Application for Phase 2a Clinical Trial of ANAVEX 2-73

May 6, 2013

Anavex Comments on FDA Plan to Expedite Approval of New Alzheimer’s Drugs

March 18, 2013

ANAVEX 2-73 Restores Mitochondrial Functionality, Blocks Cell Death and Oxidative Stress, Preventing Onset of Alzheimer’s Disease

March 12, 2013

Mitochondrial protection in mouse hippocampus against Aß25-35 toxicity is induced by the novel tetrahydrofuran derivative ANAVEX2-73, a mixed σ1 receptor and cholinergic agonist.

March 6, 2013

Anavex Retains Novak Druce Connolly Bove & Quigg to Maximize Value of Intellectual Property Portfolio

February 4, 2013

Amyloid toxicity induced by oligomeric Aβ25-35 injection is enhanced after pharmacologic or genetic invalidation of the σ1 chaperone protein

January 11, 2013

Implication of the σ1 chaperone protein in adult neurogenesis: Contribution to neuroprotection?

January 11, 2013

Anavex Appoints Tom Skarpelos as Director

January 10, 2013

ANAVEX 2-73 Shown to Block Oxidative Stress, Preventing Onset of Alzheimer’s Disease

October 18, 2012

Mitochondrial protection is induced by the novel tetrahydrofuran derivative ANAVEX2-73 after ICV injection of oligomeric Aß25-35 peptide in mice, a nontransgenic Alzheimer’s disease model.

October 13, 2012

Anavex to Present at Neuroscience 2012 in New Orleans

October 12, 2012
1
23456789101112131415161718192021222324
…2526272829…
303132333435363738394041
42

ANAVEX® is a trademark of Anavex®Life Sciences Corp. - 2019 All Rights Reserved

Go to Top